Recent advances in therapeutic strategies for triple-negative breast cancer

Triple-negative breast cancer (TNBC) is the most malignant subtype of breast cancer (BC) with a poor prognosis. Current treatment options are limited to surgery, adjuvant chemotherapy and radiotherapy; however, a proportion of patients have missed the surgical window at the time of diagnosis. TNBC i...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yun, Zhang, Huajun, Merkher, Yulia, Chen, Lin, Liu, Na, Leonov, Sergey, Chen, Yongheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422136/
https://www.ncbi.nlm.nih.gov/pubmed/36038913
http://dx.doi.org/10.1186/s13045-022-01341-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9422136/
https://www.ncbi.nlm.nih.gov/pubmed/36038913
http://dx.doi.org/10.1186/s13045-022-01341-0

Ejemplares similares